These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 25429856

  • 1. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
    Lee JW, Ryu JY, Yoon G, Jeon HK, Cho YJ, Choi JJ, Song SY, Do IG, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.
    Int J Cancer; 2015 Jul 01; 137(1):221-9. PubMed ID: 25429856
    [Abstract] [Full Text] [Related]

  • 2. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
    Lee YY, Jeon HK, Hong JE, Cho YJ, Ryu JY, Choi JJ, Lee SH, Yoon G, Kim WY, Do IG, Kim MK, Kim TJ, Choi CH, Lee JW, Bae DS, Kim BG.
    Oncotarget; 2015 Oct 27; 6(33):35040-50. PubMed ID: 26418900
    [Abstract] [Full Text] [Related]

  • 3. Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian Cancer.
    Ha H, Ryu JY, Yoon S, Cho YJ, Choi JJ, Hwang JR, Choi JY, Han HD, Lee JW.
    Anticancer Res; 2024 Oct 27; 44(10):4273-4282. PubMed ID: 39348952
    [Abstract] [Full Text] [Related]

  • 4. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissié J, Malavaud B, Waxman J, Cuvillier O.
    Cancer Res; 2010 Nov 01; 70(21):8651-61. PubMed ID: 20959468
    [Abstract] [Full Text] [Related]

  • 5. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
    Lim KG, Tonelli F, Li Z, Lu X, Bittman R, Pyne S, Pyne NJ.
    J Biol Chem; 2011 May 27; 286(21):18633-40. PubMed ID: 21464128
    [Abstract] [Full Text] [Related]

  • 6. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.
    Bai H, Li H, Li W, Gui T, Yang J, Cao D, Shen K.
    Oncotarget; 2015 Sep 22; 6(28):25520-32. PubMed ID: 26267321
    [Abstract] [Full Text] [Related]

  • 7. Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma.
    Han HD, Cho YJ, Cho SK, Byeon Y, Jeon HN, Kim HS, Kim BG, Bae DS, Lopez-Berestein G, Sood AK, Shin BC, Park YM, Lee JW.
    Mol Cancer Ther; 2016 Apr 22; 15(4):618-27. PubMed ID: 26861249
    [Abstract] [Full Text] [Related]

  • 8. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
    Nagaoka Y, Otsuki K, Fujita T, Uesato S.
    Biol Pharm Bull; 2008 Jun 22; 31(6):1177-81. PubMed ID: 18520051
    [Abstract] [Full Text] [Related]

  • 9. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
    Zhang L, Zhou D, Guan W, Ren W, Sun W, Shi J, Lin Q, Zhang J, Qiao T, Ye Y, Wu Y, Zhang Y, Zuo X, Connor KL, Xu G.
    Cell Death Dis; 2017 Dec 13; 8(12):3214. PubMed ID: 29238081
    [Abstract] [Full Text] [Related]

  • 10. c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma.
    Kim HJ, Yoon A, Ryu JY, Cho YJ, Choi JJ, Song SY, Bang H, Lee JS, Cho WC, Choi CH, Lee JW, Kim BG, Bae DS.
    Sci Rep; 2016 Dec 05; 6():38502. PubMed ID: 27917934
    [Abstract] [Full Text] [Related]

  • 11. MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model.
    Bartholomeusz C, Oishi T, Saso H, Akar U, Liu P, Kondo K, Kazansky A, Krishnamurthy S, Lee J, Esteva FJ, Kigawa J, Ueno NT.
    Mol Cancer Ther; 2012 Feb 05; 11(2):360-9. PubMed ID: 22144664
    [Abstract] [Full Text] [Related]

  • 12. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
    Li MH, Hla T, Ferrer F.
    Pediatr Blood Cancer; 2013 Sep 05; 60(9):1418-23. PubMed ID: 23704073
    [Abstract] [Full Text] [Related]

  • 13. Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer.
    Hijaz M, Chhina J, Mert I, Taylor M, Dar S, Al-Wahab Z, Ali-Fehmi R, Buekers T, Munkarah AR, Rattan R.
    Gynecol Oncol; 2016 Aug 05; 142(2):323-31. PubMed ID: 27282964
    [Abstract] [Full Text] [Related]

  • 14. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
    Li W, Li J, Wang Y, Zhang K, Li N, Tian Z, Ni B, Wang H, Ruan Z.
    Oncotarget; 2016 Dec 06; 7(49):80586-80598. PubMed ID: 27811359
    [Abstract] [Full Text] [Related]

  • 15. Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells.
    Ali JL, Lagasse BJ, Minuk AJ, Love AJ, Moraya AI, Lam L, Arthur G, Gibson SB, Morrison LC, Werbowetski-Ogilvie TE, Fu Y, Nachtigal MW.
    Int J Cancer; 2015 Mar 01; 136(5):E455-69. PubMed ID: 25227893
    [Abstract] [Full Text] [Related]

  • 16. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
    Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, Bittman R, Pyne S, Pyne NJ.
    Cell Signal; 2010 Oct 01; 22(10):1536-42. PubMed ID: 20570726
    [Abstract] [Full Text] [Related]

  • 17. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
    Saed GM, Fletcher NM, Diamond MP, Morris RT, Gomez-Lopez N, Memaj I.
    Gynecol Oncol; 2018 Mar 01; 148(3):567-575. PubMed ID: 29329880
    [Abstract] [Full Text] [Related]

  • 18. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH, Won JE, Byeon Y, Kim MG, Wi TI, Lee JM, Park YY, Lee JW, Kang TH, Jung ID, Shin BC, Ahn HJ, Lee YJ, Sood AK, Han HD, Park YM.
    Drug Deliv; 2018 Nov 01; 25(1):1394-1402. PubMed ID: 29890852
    [Abstract] [Full Text] [Related]

  • 19. Picropodophyllin inhibits epithelial ovarian cancer cells in vitro and in vivo.
    Lu X, Wang L, Mei J, Wang X, Zhu X, Zhang Q, Lv J.
    Biochem Biophys Res Commun; 2013 Jun 07; 435(3):385-90. PubMed ID: 23665331
    [Abstract] [Full Text] [Related]

  • 20. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart.
    Vessey DA, Kelley M, Zhang J, Li L, Tao R, Karliner JS.
    J Biochem Mol Toxicol; 2007 Jun 07; 21(5):273-9. PubMed ID: 17912702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.